Skip to main content
52°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Investment strategy
ETF Edge
Markets
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
CVS Health Corp
Health care industry
Companies
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
Investing
Stock markets
LVMH Moet Hennessy Louis Vuitton SE
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Novo Nordisk A/S
Business News
Social issues
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Health & Science
Business
Biotechnology
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Tesla Inc
Markets
Europe Markets
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Health care industry
U/S/ Markets
Markets
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Business News
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Investment Strategy
U/S/ Markets
Investment strategy
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Health care industry
Companies
Viking Therapeutics Inc
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Shell PLC
Europe Markets
Markets
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Technology
Snowflake Inc/
WW Grainger Inc
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
Market Outlook
World Markets
Prices
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Walt Disney Co
Reliance Steel & Aluminum Co
Markets
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
Weight loss diets
Obesity
CNBC Changemakers
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Eli Lilly and Co
Diabetes
Health insurance
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Healthy Returns
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Health care industry
Novartis AG
AstraZeneca PLC
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Pharmaceuticals
Europe News
Novo Nordisk A/S
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Weight management
Labor economy
Social issues
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Business News
Roche Holding AG
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
Tags
Health care industry
Companies
Breaking news
From
CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024
Tags
US: News
Eli Lilly and Co
Health & Science
From
CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
January 31, 2024
Tags
Health care industry
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Investment strategy
Politics
Alphabet Inc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Health care industry
Sanofi SA
Merck & Co Inc
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Viking Therapeutics Inc
Zealand Pharma A/S
JPMORGAN DRN
From
CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Eli Lilly and Co
Investing
Nestle SA
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Biotechnology
Business
Health & Science
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
Business
Humana Inc
Stock markets
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.